Viral and host factors related to the clinical outcome of COVID-19
Abstract In December 2019, coronavirus disease 2019 (COVID-19), which is caused by the
new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was …
new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was …
SARS-CoV-2 detection in patients with influenza-like illness
WH Kong, Y Li, MW Peng, DG Kong, XB Yang… - Nature …, 2020 - nature.com
Abstract Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), was first reported in Wuhan, Hubei Province, China …
syndrome coronavirus 2 (SARS-CoV-2), was first reported in Wuhan, Hubei Province, China …
Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a novel evolutionary
divergent RNA virus, is responsible for the present devastating COVID-19 pandemic. To …
divergent RNA virus, is responsible for the present devastating COVID-19 pandemic. To …
COVID-19: a new challenge for human beings
P Yang, X Wang - Cellular & molecular immunology, 2020 - nature.com
Since December 2019, just a month before the Chinese Spring Festival, multiple cases of
pneumonia of unknown etiology appeared in Wuhan, Hubei Province, China. Later, a novel …
pneumonia of unknown etiology appeared in Wuhan, Hubei Province, China. Later, a novel …
[HTML][HTML] Longitudinal analyses reveal immunological misfiring in severe COVID-19
Recent studies have provided insights into the pathogenesis of coronavirus disease 2019
(COVID-19),,–. However, the longitudinal immunological correlates of disease outcome …
(COVID-19),,–. However, the longitudinal immunological correlates of disease outcome …
Mortality of COVID-19 is associated with cellular immune function compared to immune function in Chinese Han population
Q Zeng, Y Li, G Huang, W Wu, S Dong, Y Xu - Medrxiv, 2020 - medrxiv.org
In December 2019, novel coronavirus (SARS-CoV-2) infected pneumonia occurred in
Wuhan, China. The number of cases has increased rapidly but information on the clinical …
Wuhan, China. The number of cases has increased rapidly but information on the clinical …
[HTML][HTML] Co-infection of SARS-CoV-2 and Influenza virus in Early Stage of the COVID-19 Epidemic in Wuhan, China
X Zheng, H Wang, Z Su, W Li, D Yang… - The Journal of …, 2020 - ncbi.nlm.nih.gov
In this Journal, Tang et al. have report the symptoms of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection appear very similar to influenza (1). We would like to …
coronavirus 2 (SARS-CoV-2) infection appear very similar to influenza (1). We would like to …
Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients
Z Yongchen, H Shen, X Wang, X Shi, Y Li… - Emerging microbes & …, 2020 - Taylor & Francis
Effective strategy to mitigate the ongoing pandemic of 2019 novel coronavirus (COVID-19)
require a comprehensive understanding of humoral responses against severe acute …
require a comprehensive understanding of humoral responses against severe acute …
[HTML][HTML] Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections
The pandemic 2019 novel coronavirus disease (COVID-19) shares certain clinical
characteristics with other acute viral infections. We studied the whole-blood transcriptomic …
characteristics with other acute viral infections. We studied the whole-blood transcriptomic …
Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China
The novel coronavirus disease 2019 (COVID-19) was first reported in Wuhan, China, where
the initial wave of intense community transmissions was cut short by interventions. Using …
the initial wave of intense community transmissions was cut short by interventions. Using …